Sensus Healthcare (SRTS) Stock Price, News & Analysis

Company Overview

Sensus Healthcare, Inc. is a medical device company focused on noninvasive treatments for dermatologic and oncologic conditions. The company develops and commercializes superficial radiation therapy systems designed to deliver low-energy X-rays to targeted areas of the skin while limiting exposure to surrounding tissue.

Its principal products include the SRT-100 and SRT-100 Vision systems, which are used primarily to treat non-melanoma skin cancers such as basal cell and squamous cell carcinomas, as well as certain keloid scars. The SRT-100 Vision incorporates image-guidance capabilities intended to support treatment planning and delivery. Sensus has also developed dermatology and aesthetic treatment technologies, including systems designed for transdermal drug delivery.

Founded in 2010, Sensus Healthcare is headquartered in Boca Raton, Florida. The company markets its products to dermatology practices, hospitals, cancer treatment centers and other healthcare providers in the United States and selected international markets through a combination of direct sales and distribution relationships.

Key Stats

• Today's Range: $2.92 to $3.04
• 50-Day Range: $2.85 to $3.54
• 52-Week Range: $2.66 to $5.49
• Volume: 16,438 shs
• Average Volume: 22,925 shs
• Market Capitalization: $48.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $5.83
• Consensus Rating: Moderate Buy

Sensus Healthcare Stock Analysis - MarketRank™

Sensus Healthcare scored higher than 54% of companies evaluated by MarketBeat, and ranked 373rd out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Sensus Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 4 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Sensus Healthcare has a consensus price target of $5.83, representing about 99.8% upside from its current price of $2.92.

Amount of Analyst Coverage

Sensus Healthcare has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sensus Healthcare is -3.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sensus Healthcare is -3.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Sensus Healthcare has a P/B Ratio of 1.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

1.54% of the float of Sensus Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Sensus Healthcare has a short interest ratio ("days to cover") of 8.68.

Change versus previous month

Short interest in Sensus Healthcare has recently increased by 5.10%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sensus Healthcare does not currently pay a dividend.

Dividend Growth

Sensus Healthcare does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Sensus Healthcare this week, compared to 2 articles on an average week.

Company Ownership

• Score: 3.5 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $405,230.00 in company stock, which represents 0.8431% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Sensus Healthcare insiders have bought more of their company's stock than they have sold. Specifically, they have bought $405,230.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

10.20% of the stock of Sensus Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

25.30% of the stock of Sensus Healthcare is held by institutions.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 10/05/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:SRTS
• CIK: 1494891
• Web: www.sensushealthcare.com
• Phone: (561) 922-5808
• Fax: 561-948-2071
• Employees: 60
• Year Founded: 2010

Price Target and Rating

• Average Price Target for Sensus Healthcare: $5.83
• High Price Target: $7.50
• Low Price Target: $4.00
• Potential Upside/Downside: +99.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.94)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.72 million
• Net Margins: -88.45%
• Pretax Margin: -72.53%
• Return on Equity: -21.57%
• Return on Assets: -19.20%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.71
• Quick Ratio: 4.30

Sales & Book Value

• Annual Sales: $17.51 million
• Price / Sales: 2.75
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.93 per share
• Price / Book: 1.00

Miscellaneous

• Outstanding Shares: 16,462,000
• Free Float: 14,783,000
• Market Cap: $48.07 million
• Optionable: Optionable
• Beta: 1.18